1 |
|
2 |
<p align="left"><font size="4" color="#FF9933"><b><img src="t/development.gif" width="225" height="16"></b></font></p> |
3 |
<table width="90%" border="0" cellspacing="0" cellpadding="0" align="center"> |
4 |
<tr> |
5 |
<td height="10" width="19%"> |
6 |
<div align="center"><b>PROJECT</b></div> |
7 |
</td> |
8 |
<td height="10" width="26%"> |
9 |
<div align="center"><b>INDICATION</b></div> |
10 |
</td> |
11 |
<td height="10" width="24%"> |
12 |
<div align="center"><b>STATUS</b></div> |
13 |
</td> |
14 |
</tr> |
15 |
</table> |
16 |
<table width="90%" border="1" cellspacing="0" cellpadding="0" align="center"> |
17 |
<tr> |
18 |
<td width="19%"> |
19 |
<div align="center">PLD - 116</div> |
20 |
</td> |
21 |
<td width="26%"> |
22 |
<div align="center">Inflammatory Bowel Disease (IBD)</div> |
23 |
</td> |
24 |
<td width="24%"> |
25 |
<div align="center">Preclinical Development</div> |
26 |
</td> |
27 |
</tr> |
28 |
<tr> |
29 |
<td width="19%"> |
30 |
<div align="center">PLD - 117</div> |
31 |
</td> |
32 |
<td width="26%"> |
33 |
<div align="center">Oncology<br> |
34 |
Hematology</div> |
35 |
</td> |
36 |
<td width="24%"> |
37 |
<div align="center">Preclinical Development</div> |
38 |
</td> |
39 |
</tr> |
40 |
<tr> |
41 |
<td width="19%"> |
42 |
<div align="center">PLD - 118</div> |
43 |
</td> |
44 |
<td width="26%"> |
45 |
<div align="center">Anti-fungal</div> |
46 |
</td> |
47 |
<td width="24%"> |
48 |
<div align="center">Preclinical Development</div> |
49 |
</td> |
50 |
</tr> |
51 |
<tr> |
52 |
<td width="19%"> |
53 |
<div align="center">PLR - 1</div> |
54 |
</td> |
55 |
<td width="26%"> |
56 |
<div align="center">Anti-infective</div> |
57 |
</td> |
58 |
<td width="24%"> |
59 |
<div align="center">Discovery</div> |
60 |
</td> |
61 |
</tr> |
62 |
<tr> |
63 |
<td width="19%"> |
64 |
<div align="center">PLR - 13</div> |
65 |
</td> |
66 |
<td width="26%"> |
67 |
<div align="center">Inflammation<br> |
68 |
Asthma</div> |
69 |
</td> |
70 |
<td width="24%"> |
71 |
<div align="center">Discovery</div> |
72 |
</td> |
73 |
</tr> |
74 |
<tr> |
75 |
<td width="19%"> |
76 |
<div align="center">PLR - 9</div> |
77 |
</td> |
78 |
<td width="26%"> |
79 |
<div align="center">Anti-infective</div> |
80 |
</td> |
81 |
<td width="24%"> |
82 |
<div align="center">Discovery</div> |
83 |
</td> |
84 |
</tr> |
85 |
<tr> |
86 |
<td width="19%"> |
87 |
<div align="center">PLR - 14</div> |
88 |
</td> |
89 |
<td width="26%"> |
90 |
<div align="center">Inflammation<br> |
91 |
RA, IBD</div> |
92 |
</td> |
93 |
<td width="24%"> |
94 |
<div align="center">Discovery</div> |
95 |
</td> |
96 |
</tr> |
97 |
</table> |
98 |
<table width="100%" border="0" cellspacing="3" cellpadding="0"> |
99 |
<tr> |
100 |
<td> |
101 |
<hr size="1" width="100%"> |
102 |
</td> |
103 |
</tr> |
104 |
</table> |
105 |
<p><img src="t/generics.gif" width="225" height="16"></p> |
106 |
<table width="90%" align="center" border="0" cellspacing="0" cellpadding="0"> |
107 |
<tr> |
108 |
<td width="25%" height="35"> |
109 |
<div align="center"><b>GENERIC PRODUCT</b></div> |
110 |
</td> |
111 |
<td width="23%" height="35"> |
112 |
<div align="center"><b>FIRST REGISTRATION EXPECTED</b> </div> |
113 |
</td> |
114 |
<td width="25%" height="35"> |
115 |
<div align="center"><b>GENERIC PRODUCT</b></div> |
116 |
</td> |
117 |
<td width="27%" height="35"> |
118 |
<div align="center"><b>FIRST REGISTRATION EXPECTED</b></div> |
119 |
</td> |
120 |
</tr> |
121 |
<tr> |
122 |
<td colspan="4"> |
123 |
<table width="100%" border="1" cellspacing="0" cellpadding="0"> |
124 |
<tr> |
125 |
<td width="25%">Simvastatin</td> |
126 |
<td width="23%"> |
127 |
<div align="center">2001</div> |
128 |
</td> |
129 |
<td width="25%">Losartan</td> |
130 |
<td width="27%"> |
131 |
<div align="center">2002</div> |
132 |
</td> |
133 |
</tr> |
134 |
<tr> |
135 |
<td width="25%">Loratadin</td> |
136 |
<td width="23%"> |
137 |
<div align="center">2001</div> |
138 |
</td> |
139 |
<td width="25%">Carvedilol</td> |
140 |
<td width="27%"> |
141 |
<div align="center">2002</div> |
142 |
</td> |
143 |
</tr> |
144 |
<tr> |
145 |
<td width="25%">Erythropoietin</td> |
146 |
<td width="23%"> |
147 |
<div align="center">2001</div> |
148 |
</td> |
149 |
<td width="25%">Bisoprolol</td> |
150 |
<td width="27%"> |
151 |
<div align="center">2003</div> |
152 |
</td> |
153 |
</tr> |
154 |
<tr> |
155 |
<td width="25%">Warfarin</td> |
156 |
<td width="23%"> |
157 |
<div align="center">2001</div> |
158 |
</td> |
159 |
<td width="25%">Losartan+HCTZ</td> |
160 |
<td width="27%"> |
161 |
<div align="center">2003</div> |
162 |
</td> |
163 |
</tr> |
164 |
<tr> |
165 |
<td width="25%">Diklofenac</td> |
166 |
<td width="23%"> |
167 |
<div align="center">2001</div> |
168 |
</td> |
169 |
<td width="25%">Clarithromycin</td> |
170 |
<td width="27%"> |
171 |
<div align="center">2003</div> |
172 |
</td> |
173 |
</tr> |
174 |
<tr> |
175 |
<td width="25%">Ca folinat</td> |
176 |
<td width="23%"> |
177 |
<div align="center">2001</div> |
178 |
</td> |
179 |
<td width="25%">Venlafaxine</td> |
180 |
<td width="27%"> |
181 |
<div align="center">2003</div> |
182 |
</td> |
183 |
</tr> |
184 |
<tr> |
185 |
<td width="25%">Ondansetron</td> |
186 |
<td width="23%"> |
187 |
<div align="center">2002</div> |
188 |
</td> |
189 |
<td width="25%">Interferon alpha</td> |
190 |
<td width="27%"> |
191 |
<div align="center">2003</div> |
192 |
</td> |
193 |
</tr> |
194 |
<tr> |
195 |
<td width="25%">Torasemid</td> |
196 |
<td width="23%"> |
197 |
<div align="center">2002</div> |
198 |
</td> |
199 |
<td width="25%">Paroxetin</td> |
200 |
<td width="27%"> |
201 |
<div align="center">2003</div> |
202 |
</td> |
203 |
</tr> |
204 |
<tr> |
205 |
<td width="25%">Amlodipin</td> |
206 |
<td width="23%"> |
207 |
<div align="center">2002</div> |
208 |
</td> |
209 |
<td width="25%">HGH</td> |
210 |
<td width="27%"> |
211 |
<div align="center">2003</div> |
212 |
</td> |
213 |
</tr> |
214 |
<tr> |
215 |
<td width="25%">Risperidone</td> |
216 |
<td width="23%"> |
217 |
<div align="center">2002</div> |
218 |
</td> |
219 |
<td width="25%">Meloxicam</td> |
220 |
<td width="27%"> |
221 |
<div align="center">2003</div> |
222 |
</td> |
223 |
</tr> |
224 |
<tr> |
225 |
<td width="25%">Alendronate</td> |
226 |
<td width="23%"> |
227 |
<div align="center">2002</div> |
228 |
</td> |
229 |
<td width="25%">Interferon beta</td> |
230 |
<td width="27%"> |
231 |
<div align="center">2004</div> |
232 |
</td> |
233 |
</tr> |
234 |
<tr> |
235 |
<td width="25%">Ciprofloxacin</td> |
236 |
<td width="23%"> |
237 |
<div align="center">2002</div> |
238 |
</td> |
239 |
<td width="25%">Indapamide</td> |
240 |
<td width="27%"> |
241 |
<div align="center">2004</div> |
242 |
</td> |
243 |
</tr> |
244 |
<tr> |
245 |
<td width="25%">Mesalazin</td> |
246 |
<td width="23%"> |
247 |
<div align="center">2002</div> |
248 |
</td> |
249 |
<td width="25%">Cytostatics (9)</td> |
250 |
<td width="27%"> |
251 |
<div align="center">2001-2003</div> |
252 |
</td> |
253 |
</tr> |
254 |
<tr> |
255 |
<td width="25%">G-CSF </td> |
256 |
<td width="23%"> |
257 |
<div align="center">2002</div> |
258 |
</td> |
259 |
<td width="25%">OTC products (9)</td> |
260 |
<td width="27%"> |
261 |
<div align="center">2001-2003</div> |
262 |
</td> |
263 |
</tr> |
264 |
</table> |
265 |
</td> |
266 |
</tr> |
267 |
</table> |